Another study revealed that combined exposure of melanoma cells to metformin (1 mM) and binimetinib (2 μM) showed a reduced number of cells undergoing S phase replication compared to the control and led to G0/G1 arrest through the cyclin D/CDK4/CDK6 pathway [36]. The gene discussed is CDK4; the disease is melanoma.